Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 1558480
[patent_doc_number] => 06436398
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-08-20
[patent_title] => '2 -substituted-6-alkylidene penicillanic acid derivatives as -lactamase inhibitors'
[patent_app_type] => B2
[patent_app_number] => 09/725611
[patent_app_country] => US
[patent_app_date] => 2000-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16853
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/436/06436398.pdf
[firstpage_image] =>[orig_patent_app_number] => 09725611
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/725611 | 2 -substituted-6-alkylidene penicillanic acid derivatives as -lactamase inhibitors | Nov 28, 2000 | Issued |
Array
(
[id] => 1414168
[patent_doc_number] => 06525038
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Synergistic compositions for the selective control of tumor tissue'
[patent_app_type] => B1
[patent_app_number] => 09/713449
[patent_app_country] => US
[patent_app_date] => 2000-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5076
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/525/06525038.pdf
[firstpage_image] =>[orig_patent_app_number] => 09713449
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/713449 | Synergistic compositions for the selective control of tumor tissue | Nov 14, 2000 | Issued |
Array
(
[id] => 1363331
[patent_doc_number] => 06569853
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-27
[patent_title] => 'Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders'
[patent_app_type] => B1
[patent_app_number] => 09/706929
[patent_app_country] => US
[patent_app_date] => 2000-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8061
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/569/06569853.pdf
[firstpage_image] =>[orig_patent_app_number] => 09706929
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/706929 | Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders | Nov 5, 2000 | Issued |
09/703955 | HIV treatment | Oct 31, 2000 | Abandoned |
Array
(
[id] => 1586174
[patent_doc_number] => 06358961
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'Farnesyltransferase inhibiting quinazolinones'
[patent_app_type] => B1
[patent_app_number] => 09/687153
[patent_app_country] => US
[patent_app_date] => 2000-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9676
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 805
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/358/06358961.pdf
[firstpage_image] =>[orig_patent_app_number] => 09687153
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/687153 | Farnesyltransferase inhibiting quinazolinones | Oct 12, 2000 | Issued |
Array
(
[id] => 1459079
[patent_doc_number] => 06426340
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-30
[patent_title] => 'Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-FUDCA)'
[patent_app_type] => B1
[patent_app_number] => 09/684585
[patent_app_country] => US
[patent_app_date] => 2000-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3096
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/426/06426340.pdf
[firstpage_image] =>[orig_patent_app_number] => 09684585
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/684585 | Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-FUDCA) | Oct 5, 2000 | Issued |
Array
(
[id] => 1454194
[patent_doc_number] => 06462087
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-08
[patent_title] => 'Anti-tumor composition'
[patent_app_type] => B1
[patent_app_number] => 09/678406
[patent_app_country] => US
[patent_app_date] => 2000-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6100
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/462/06462087.pdf
[firstpage_image] =>[orig_patent_app_number] => 09678406
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/678406 | Anti-tumor composition | Oct 2, 2000 | Issued |
Array
(
[id] => 1454065
[patent_doc_number] => 06462062
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-08
[patent_title] => 'Compounds and methods for use thereof in the treatment of cancer or viral infections'
[patent_app_type] => B1
[patent_app_number] => 09/670168
[patent_app_country] => US
[patent_app_date] => 2000-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11709
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/462/06462062.pdf
[firstpage_image] =>[orig_patent_app_number] => 09670168
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/670168 | Compounds and methods for use thereof in the treatment of cancer or viral infections | Sep 25, 2000 | Issued |
Array
(
[id] => 1316675
[patent_doc_number] => 06608096
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-19
[patent_title] => 'Compounds and methods for use thereof in the treatment of cancer or viral infections'
[patent_app_type] => B1
[patent_app_number] => 09/670166
[patent_app_country] => US
[patent_app_date] => 2000-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11746
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/608/06608096.pdf
[firstpage_image] =>[orig_patent_app_number] => 09670166
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/670166 | Compounds and methods for use thereof in the treatment of cancer or viral infections | Sep 25, 2000 | Issued |
Array
(
[id] => 1462945
[patent_doc_number] => 06350776
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-26
[patent_title] => 'Method of treating proliferative disease with lycopene and alpha-tocopherol'
[patent_app_type] => B1
[patent_app_number] => 09/665937
[patent_app_country] => US
[patent_app_date] => 2000-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 3027
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/350/06350776.pdf
[firstpage_image] =>[orig_patent_app_number] => 09665937
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/665937 | Method of treating proliferative disease with lycopene and alpha-tocopherol | Sep 19, 2000 | Issued |
09/657670 | Combined estrogen blockade of the breast with exemestane and raloxifene | Sep 7, 2000 | Abandoned |
Array
(
[id] => 1570622
[patent_doc_number] => 06498188
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-24
[patent_title] => 'Methods of treatment for cancer or viral infections'
[patent_app_type] => B1
[patent_app_number] => 09/645427
[patent_app_country] => US
[patent_app_date] => 2000-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9859
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/498/06498188.pdf
[firstpage_image] =>[orig_patent_app_number] => 09645427
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/645427 | Methods of treatment for cancer or viral infections | Aug 23, 2000 | Issued |
09/554665 | Therapeutic treatment for chronic myeloid leukemia and acute lymphoid leukemia | Aug 16, 2000 | Abandoned |
Array
(
[id] => 1575262
[patent_doc_number] => 06469022
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-22
[patent_title] => 'Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents'
[patent_app_type] => B1
[patent_app_number] => 09/486938
[patent_app_country] => US
[patent_app_date] => 2000-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6412
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/469/06469022.pdf
[firstpage_image] =>[orig_patent_app_number] => 09486938
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/486938 | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents | Aug 16, 2000 | Issued |
Array
(
[id] => 1494610
[patent_doc_number] => 06342506
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-29
[patent_title] => 'Method for treating cancer with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof'
[patent_app_type] => B1
[patent_app_number] => 09/638354
[patent_app_country] => US
[patent_app_date] => 2000-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 6308
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/342/06342506.pdf
[firstpage_image] =>[orig_patent_app_number] => 09638354
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/638354 | Method for treating cancer with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof | Aug 14, 2000 | Issued |
Array
(
[id] => 1440451
[patent_doc_number] => 06495600
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-17
[patent_title] => 'Method and composition for selectively inhibiting melanoma'
[patent_app_type] => B1
[patent_app_number] => 09/635385
[patent_app_country] => US
[patent_app_date] => 2000-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7556
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/495/06495600.pdf
[firstpage_image] =>[orig_patent_app_number] => 09635385
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/635385 | Method and composition for selectively inhibiting melanoma | Aug 8, 2000 | Issued |
Array
(
[id] => 1602800
[patent_doc_number] => 06432979
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Method of treating or inhibiting colonic polyps and colorectal cancer'
[patent_app_type] => B1
[patent_app_number] => 09/634787
[patent_app_country] => US
[patent_app_date] => 2000-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15565
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 780
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/432/06432979.pdf
[firstpage_image] =>[orig_patent_app_number] => 09634787
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/634787 | Method of treating or inhibiting colonic polyps and colorectal cancer | Aug 8, 2000 | Issued |
Array
(
[id] => 4409724
[patent_doc_number] => 06310053
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-30
[patent_title] => 'Long-acting oxytetracycline composition'
[patent_app_type] => 1
[patent_app_number] => 9/617795
[patent_app_country] => US
[patent_app_date] => 2000-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2424
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/310/06310053.pdf
[firstpage_image] =>[orig_patent_app_number] => 617795
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/617795 | Long-acting oxytetracycline composition | Jul 16, 2000 | Issued |
Array
(
[id] => 1502488
[patent_doc_number] => 06465020
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Use of garlic extract as both preventive and therapeutic agents for human prostate and bladder cancers'
[patent_app_type] => B1
[patent_app_number] => 09/610322
[patent_app_country] => US
[patent_app_date] => 2000-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 3351
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465020.pdf
[firstpage_image] =>[orig_patent_app_number] => 09610322
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/610322 | Use of garlic extract as both preventive and therapeutic agents for human prostate and bladder cancers | Jul 4, 2000 | Issued |
Array
(
[id] => 1485720
[patent_doc_number] => 06365607
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'Anticachectic composition'
[patent_app_type] => B1
[patent_app_number] => 09/605628
[patent_app_country] => US
[patent_app_date] => 2000-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6195
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365607.pdf
[firstpage_image] =>[orig_patent_app_number] => 09605628
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/605628 | Anticachectic composition | Jun 27, 2000 | Issued |